Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical

RSS  

Articles

  • Subcutaneous IVIG for Treatment of Myasthenia Gravis

    A Phase II trial comparing subcutaneous (SC) administration of pooled immunoglobulin to intravenous (IV) administration of immunoglobulin in 23 patients with seropositive myasthenia gravis demonstrated a stable course after transition from IV to SC.

  • Inclusion Body Myositis: Variability and Clinical Subsets

    Inclusion body myositis (IBM) is a progressive myopathy characterized by prominent finger flexor and quadriceps involvement. Black patients with IBM have more prominent proximal weakness, in addition to finger flexion and quadriceps weakness. Female patients have less prominent finger flexion and quadriceps weakness and slower progression, whereas younger patients had a greater delay in diagnosis. There are variability and distinct clinical subsets among IBM patients, which can have implications in terms of timely diagnosis and possibly response to treatments.

  • The Neural Pathways of Pain Treatment Response in Small-Fiber Neuropathy

    Pain in peripheral neuropathy, referred to as neuropathic pain, is thought to result from overexpression of pain receptors, regeneration of hypersensitive nerve sprouts, and denervation hypersensitivity of neurons in the sensory ganglia. Additionally, activation of the pain pathways appears to induce secondary structural and functional changes in the brain that contribute to pain perception, persistence, and response.

  • Focused Ultrasound Ablation of the Subthalamic Nucleus for Parkinson’s Disease Tremor

    This paper demonstrated the long-term efficacy and safety of unilateral magnetic resonance imaging-guided high-frequency ultrasound subthalamotomy for Parkinson’s disease patients with motor fluctuations and dyskinesia three years after the procedure.

  • Role of the Hypothalamus in Migraine and Cluster Headaches

    The hypothalamus plays a regulatory role in both migraine and cluster headaches. However, the two headache types have distinctive clinical features, characteristic areas of resting state functional connectivity on magnetic resonance imaging, and different genetic chronobiological associations.

  • The Hippocratic Oath: Are We Hurting Ourselves and Each Other?

    While there are multiple definitions of well-being, it commonly is described as a dynamic and ongoing process involving self-awareness and healthy choices, resulting in a successful and balanced lifestyle. Burnout results from chronic stress, which leads to emotional exhaustion, depersonalization, and decreased feelings of personal accomplishment. Unfortunately, given the rigor of the healthcare profession, healthcare providers often need to remember to consider their emotional well-being while navigating the shift toward an oligopolistic medical industry that perpetuates the cycle by focusing on profit — totaling 18.3% of the gross domestic product.

  • Doxycycline Demonstrates Protection Against Sexually Transmitted Infections

    Common antibiotic could be a key tool to help stem the rising tide of reported cases.

  • Poor Sleep Patterns Could Raise Stroke Risk

    Researchers provide another reason why patients should be resting well every night.

  • An Oral PCSK9 Inhibitor — Coming Soon?

    A Phase IIb study of four doses of MK-0616, an orally administered PCSK9 inhibitor, compared to placebo showed significant reductions in LDL cholesterol levels without any differences in adverse effects over eight weeks.

  • Cardiovascular Outcomes with Bempedoic Acid, a New Statin Alternative

    A trial of bempedoic acid vs. placebo for statin-intolerant patients showed bempedoic acid significantly lowered LDL cholesterol levels and prevented more major adverse cardiovascular events after a median follow-up of 41 months. Although nonserious side effects were numerically higher for those on bempedoic acid, serious adverse events were not significantly different from placebo.